Reaching Training Based on Robotic Hybrid Assistance for Stroke Patients (RETRAINER-S1)

May 28, 2017 updated by: Dr. Franco Molteni, Villa Beretta Rehabilitation Center

Stroke is the third most common cause of death and the main cause of acquired adult disability in high-income countries. The most common deficit after stroke is motor impairment of the contralateral arm, with more than 80% of stroke survivors experiencing this condition in the acute phase, and only half regaining some useful upper limb function after six months.

Within the European project RETRAINER (grant agreement No 644721), the consortium developed a platform for the rehabilitation of the upper limb after stroke, which combines a passive arm exoskeleton for weight relief supporting both shoulder and elbow movements, Functional Electrical Stimulation (FES) of the two-most impaired muscles of the affected side, interactive objects, and voluntary effort. The system also provides a graphical user interface which helps the therapist set the training session and save the training data and parameters, and provides the subject a visual feedback about his/her active involvement in the exercise. The training consists of the execution of a series of exercises involving the affected arm during daily life activities. Typical exercises are anterior reaching on a plane or in the space, moving an object on a plane or in the space, moving the hand to the mouth, with or without an object in the hand, and lateral elevation of the shoulder.

The aim of this clinical study it to evaluate the efficacy of this novel training platform on patients between two weeks and nine months after their first stroke, who preserved at least a visible muscle contraction for the arm and shoulder muscles. Participants are randomized in an experimental and a control group. The control group is trained with an advanced rehabilitative program, including physical training, occupational therapy, FES, and virtual reality, while the experimental group is trained with the RETRAINER system for about 30 minutes, in addition to the same program of the control group. The daily training time is the same for the two groups. The intervention consists of three sessions a week for nine weeks. Patients are assessed at baseline, soon after the end of the intervention, and in a 4-week follow-up visits. It is planned to recruit 68 subjects for this study.

Since the RETRAINER platform was built on the up-to-date theory of motor re-learning, which supports task-oriented repetitive training, a close temporal association between motor intention and stimulated motor response, and an intensive and frequent training paradigm, the study's hypothesis is that the experimental group shows a greater treatment effect than the control group.

Study Overview

Status

Unknown

Conditions

Detailed Description

This is multi-center randomized controlled trial designed according to the CONSORT Statement recommendations. A total of 68 patients will be recruited in the two centers. This sample size was a-priori calculated as capable to detect a clinically important between-group difference of 5.7 points in the primary endpoint Action Research Arm Test, considering a standard deviation of 12.5, a type I error of 5%, and a power of 80%.

More technical details on the RETRAINER platform for the rehabilitation of the arm are here reported.

The experimental setup consists of a lightweight passive arm exoskeleton for weight compensation, a current-controlled stimulator with 2 channels of stimulation and 2 channels of EMG recordings developed by Hasomed GmbH, and interactive objects, which are daily life objects equipped with RFID (Radio Frequency Identification) tags used to identify the target positions so as to drive the execution of the rehabilitation exercises. A suitable reader is embedded in the exoskeleton with the antenna on the wrist joint. The control system is shared between an Embedded Control System (ECS), running on a BeagleBoneBlackTM, for real-time operation, and a Windows-based table (Microsoft Surface 3 running Windows 8), which provides a graphical user interface (GUI) for the therapist and the patient.

The exoskeleton is characterized by four degrees of freedom (DOFs): three of them, e.g. shoulder elevation, shoulder rotation in the transversal plane and elbow flex-extension, are equipped with angle sensors (Vert-X 13 E, ConTelec AG) to measure the position and electromagnetic brakes to avoid the fatiguing and unnecessary use of FES to hold a target position once reached. The additional DOF is provided by an inclination module, which enables the patient to move the trunk 20° forward without constriction. In addition to the 4 DOFs, the humeral rotation, the prono-supination as well as the length of the forearm and the upper arm can be adjusted at the beginning of the training session at subject-specific positions. The gravity compensation modules for upper arm and forearm consist of a carbon fiber-tube with springs inside whose pre-tension can be adjusted at the beginning of the training session in order to change the level of compensation. Thanks to the adjustability of the lengths and the level of compensation, the exoskeleton can fit and support patients within 5th and 95th female/male percentile. The exoskeleton can be mounted on the user's wheelchair or on a normal chair by means of a universal clamping mechanism which assures easy and stable mounting. The exoskeleton weights about 4kg plus 2kg for the clamping mechanism.

In addition to the support provided by the exoskeleton, EMG-triggered FES is delivered to two muscles, selected by the therapist based on the subject-specific needs. For each stimulated muscle, the residual volitional EMG signal is detected and used to trigger the onset of a predetermined stimulation sequence applied to the muscle itself. In case the muscle does not reach the pre-defined threshold, the stimulation sequence is automatically started after a time-out. EMG signals are acquired at 4kHz, the stimulation frequency is set at 25Hz, the pulse width is fixed at 300µs, while the stimulation intensity is set at the beginning of the training session on each muscle individually at a value tolerated by the subject and able to induce a functional movement. Separate EMG and stimulation (Pals® electrodes, Axelgaard Manufacturing Ltd) are placed over each muscle belly. When the stimulation starts, EMG signals are continuously measured in order to provide a visual feedback about the patient's volitional involvement at the end of the execution of each task. An adaptive linear prediction filter is used to estimate the volitional EMG during hybrid muscle contractions. If the mean value of the volitional EMG estimate during the stimulation phase is over a pre-defined threshold, a happy emoji is shown to the patient through the GUI; conversely, if it is below the pre-defined threshold a sad emoji is shown in order to promote the active involvement of the subject. A fast and automatic calibration procedure is required before the beginning of each session. This procedure aims at setting the current amplitude and the EMG threshold values. During the procedure the subject is asked to be relaxed. Specifically, three thresholds are set on each muscle: two of them are used to trigger the stimulation, one in case the muscle is activated as first and one in case the muscle is activated as second one; the third threshold is used to define the subject's active involvement in the task. The thresholds are defined as twice the mean volitional EMG during a phase of no stimulation (first threshold), during a phase of stimulation of the other muscle (second threshold), and during a phase of simultaneous stimulation of the two muscles (third threshold).

The control interface of the system, implemented in .Net 4.6, provides a GUI including multiple software tools to organize rehabilitation exercises and monitor rehabilitation progress. The heart of the control interface is a State Machine, which drives both the parameterization and the execution of the exercises. Each exercise is divided into single tasks: the State Machine drives the exercise execution throughout the tasks, while the execution of each single task is controlled by the ECS. The ECS controls all the modules requiring real time constraints, such as the stimulator, the FES controller and the exoskeleton sensors. To keep the control interface and the ESC synchronized, a strict master slave concept using a custom made communication protocol was implemented, meaning that the ECS must not act independently, but only reacts to commands sent by the high level control. Transitions between states of the state machine and thus tasks of the exercise are triggered by angle sensors data, RFID data or a timer (depending on the task). Transitions have to fulfill certain conditions, so called guards. These guards are predefined for each task and have to be parameterized as described in the Section D. The GUI guides the user through the training by providing visual instructions and feedback.

The workflow of a typical training session consists of four main phases: the setting, donning and parameterization of the system, and the training following a pre-defined sequence of exercises. The control interface supports the therapist and the patient throughout all the phases via the GUI.

The setting starts with the therapist creating a new user, or selecting an existent one, and selecting the exercises. Afterwards, the donning phase starts with the placement of the EMG and stimulation electrodes. Once the electrodes placement is checked, the therapist should adjust the exoskeleton lengths to fit with the patient and let the patient don the exoskeleton. The following step is the calibration of the FES controller by means of the automatic procedure previously described. The therapist sets the gravity compensation both at the arm and forearm level and saves the final exoskeleton settings. On the following training days, the setting and donning procedure is partly simplified since the therapist can load the settings of the previous day and eventually adjust them.

The parameterization step is designed to set the guards of the State Machine. In this process the GUI guides the patient and the therapist through each task of the selected exercises without stimulation. The patient-specific parameters for each task, such as the target positions, the desired time for the execution of each task, and the time of the relax phases, are determined. At the end of the parameterization phase, all the parameters are stored and the training session can start.

The training consists of the execution of a series of exercises involving the arm during daily life activities. Typical exercises are anterior reaching on a plane or in the space, moving an object on a plane or in the space, moving the hand to the mouth, with or without an object in the hand, and lateral elevation of the shoulder. The execution of the exercises is controlled by the control interface which leads the patient throughout the single tasks by means of both visual and audio messages via the GUI.

Study Type

Interventional

Enrollment (Anticipated)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Konigstein im Taunus, Germany, 61462
        • Recruiting
        • Asklepios Neurologische Klinik Falkenstein
    • Lecco
      • Costa Masnaga, Lecco, Italy, 23845
        • Recruiting
        • Villa Beretta Rehabilitation Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria are:

  • Adults male and/or female, 18-85 years old
  • Patients who have suffered a first stroke with major unilateral functional impairment
  • Acute event between two weeks and nine months before study enrollment
  • Motricity Index of the affected side must be under 80% of best expected performance.
  • No major contralateral impairment must be present (Motricity Index of the non-affected side more than 80% of normality)
  • Residual muscular activity for arm and shoulder muscles (MRC > o = 1)
  • Mini-Mental State Examination > 20

Exclusion criteria:

  • Limitation for using the device due to impairment of Passive Range of Motion and/or Pain due to Spasticity evaluated using Modified Ashworth Scale
  • Previus history of major neurological or psychiatric disorders
  • allergy to electrodes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: RETRAINER-S1 & Conventional Therapy
27 sessions, 3 sessions per week for a total of 9 weeks. Each session consists of 30-minute training with the RETRAINER-S1 system plus 60 minutes of conventional therapy. The training session is customized on the patients' need and can be adapted to their improvement during the intervention.

It consists of the execution of different exercises with the affected arm supported by the RETRAINER-S1 device. The subject is actively involved in the exercises and the system provides two types of support: weight relief and FES. The following exercises can be performed:

  • anterior reaching (in a plane or in the space)
  • lateral elevation of the arm
  • hand to mouth movements with or without an object in the hand
  • moving objects on a plane or in the space. A subset of exercises is defined based on the patient's capability and the training time is equally shared between the selected exercises. The different training sessions can include different exercises and a different number of repetition for each exercise.

It consists of a combination of different treatment modalities among the following, based on the petient's specific needs:

  • Upper limb passive motion
  • Arm Cycle ergometer with or without FES
  • Neuro Muscular Electrical Stimulation
  • Upper limb exercises using augmented or virtual reality environment
  • Occupational therapy exercises
  • Constraint induced movement therapy
  • Upper limb active movement (reaching, grasping, elevation, spatial orientation)
  • Repetitive task training
  • Mirror therapy
  • Writing training
  • Chemodenervation Therapy
Active Comparator: Conventional Therapy
27 sessions, 3 sessions per week for a total of 9 weeks. Each session lasts about 90 minutes and consists of different training modalities typically used in the rehabilitation of the arm after stroke. The training session is customized on the patients' need and can be adapted to their improvement during the intervention.

It consists of a combination of different treatment modalities among the following, based on the petient's specific needs:

  • Upper limb passive motion
  • Arm Cycle ergometer with or without FES
  • Neuro Muscular Electrical Stimulation
  • Upper limb exercises using augmented or virtual reality environment
  • Occupational therapy exercises
  • Constraint induced movement therapy
  • Upper limb active movement (reaching, grasping, elevation, spatial orientation)
  • Repetitive task training
  • Mirror therapy
  • Writing training
  • Chemodenervation Therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Action Research Arm Test
Time Frame: 9 weeks

19-item outcome measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from:

  • 3: Performs test normally
  • 2: Completes test, but takes abnormally long or has great difficulty
  • 1: Performs test partially
  • 0: Can perform no part of test
9 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Action Research Arm Test
Time Frame: baseline; 13 weeks

9-item outcome measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from:

  • 3: Performs test normally
  • 2: Completes test, but takes abnormally long or has great difficulty
  • 1: Performs test partially
  • 0: Can perform no part of test
baseline; 13 weeks
Medical Research Council
Time Frame: baseline; 9 weeks; 13 weeks
A standardized assessment to measure muscle strength; Score range 0-5 (minimum 0, maximum 5)
baseline; 9 weeks; 13 weeks
Motricity index
Time Frame: baseline; 9 weeks; 13 weeks
Outcome measure to evaluate motor impairment after stroke; 2 sub-scales (arm and leg); each subscale ranges from 0 (maximal impairment) to 100 (no impairment)
baseline; 9 weeks; 13 weeks
Motor Activity Log
Time Frame: baseline; 9 weeks; 13 weeks

Semi-structured interview to assess arm function. Individuals are asked to rate Quality of Movement and Amount of Movement during 30 daily functional tasks. Target tasks include object manipulation (e.g. pen, fork, comb, and cup) as well as the use of the arm during gross motor activities (e.g. transferring to a car, steadying oneself during standing, pulling a chair into a table while sitting).

Items scored on a 6-point ordinal scale (0 not used, 6 as good as before).

baseline; 9 weeks; 13 weeks
Box & Blocks Test
Time Frame: baseline; 9 weeks; 13 weeks

It assesses unilateral gross manual dexterity. Individuals are seated at a table, facing a rectangular box that is divided into two square compartments of equal dimension by means of a partition.

One hundred and fifty, 2.5 cm, colored, wooden cubes or blocks are placed in one compartment or the other. The individual is instructed to move as many blocks as possible, one at a time, from one compartment to the other for a period of 60 seconds.

To administer the test, the examiner is seated opposite the individual in order to observe test performance.

The test is scored by counting the number of blocks carried over the partition from one compartment to the other during the one-minute trial period.

baseline; 9 weeks; 13 weeks
Stroke Specific Quality Of Life scale
Time Frame: baseline; 9 weeks; 13 weeks

It assesses the health-related quality of life specific to stroke survivors.

It consists of 49 items, each assessed on 5-point Guttman-type scales. Score range: 49-245 with higher score indicating better functioning. It covers 12 domains which are:

  • Mobility
  • Energy
  • Upper Extremity Function
  • Work and Productivity
  • Mood
  • Self-care
  • Social Roles
  • Family Roles
  • Vision
  • Language
  • Thinking
  • Personality
baseline; 9 weeks; 13 weeks
Modified Ashworth Scale
Time Frame: baseline; 9 weeks; 13 weeks

It measures spasticity. It consists of a test resistance to passive movement about a joint with varying degrees of velocity. Scores range from 0-5; a score of 0 indicates no resistance, 5 indicates rigidity.

Target muscles: Pectoralis Major, Deltoids, Biceps and Triceps

baseline; 9 weeks; 13 weeks
Instrumental assessment
Time Frame: baseline; 9 weeks; 13 weeks

Dynamic EMG signals of the Pectoralis Major, Deltoids, Biceps and Triceps muscles as well as kinematic data are measured during free-movement of the arm (e.g. hand to mouth, reaching).

Range of motion, repeatability, smoothness, movement time, co-contractions and activation patterns are evaluated.

baseline; 9 weeks; 13 weeks
System Usability Scale
Time Frame: 9 weeks
A 10-item questionnaire to measure system usability. Each item has five response options, from "Strongly agree" to "Strongly disagree".
9 weeks
Technology Acceptance Model
Time Frame: 9 weeks

A standardized questionnaire that measures technology acceptance. The questionnaire consists of 2 parts, 10 items to measure usefulness and 10 items to measure ease of use.

Participants are asked to provide their level of agreement on a 7-point scale (1=strongly disagree and 7 = strongly agree).

9 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 10, 2016

Primary Completion (Anticipated)

April 1, 2018

Study Completion (Anticipated)

May 1, 2018

Study Registration Dates

First Submitted

May 22, 2017

First Submitted That Met QC Criteria

May 28, 2017

First Posted (Actual)

May 31, 2017

Study Record Updates

Last Update Posted (Actual)

May 31, 2017

Last Update Submitted That Met QC Criteria

May 28, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • RETRAINER-S1
  • 644721 (Other Grant/Funding Number: European Union's Horizon 2020 research and innovation program)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on RETRAINER-S1

3
Subscribe